Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s436359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Jilei Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, People's Republic of China. Hauptthemen laut MEDLINE: Berberine, Toll-Like Receptor 4, Hypoxia-Inducible Factor 1, alpha Subunit, NF-kappa B. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, People's Republic of China.
- Department of Dermatology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, People's Republic of China.
- Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
ORCID-Profile: Jilei Li, Wenchao Dan, Yichong Wang
Zitieren
APA
Li, J., Dan, W., Zhang, C., Liu, N., Wang, Y., Liu, J., & Zhang, S. (2024). Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s436359
Vancouver
Li J, Dan W, Zhang C, Liu N, Wang Y, Liu J, et al. Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s436359
BibTeX
@article{Li2024,
author = {Li, Jilei and Dan, Wenchao and Zhang, Chenchen and Liu, Nian and Wang, Yichong and Liu, Jixiang and Zhang, Shengsheng},
title = {Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s436359}
}
EUVIMED